Format

Send to

Choose Destination
Methods Mol Biol. 2016;1439:47-63. doi: 10.1007/978-1-4939-3673-1_3.

High-Throughput Screening Using Mass Spectrometry within Drug Discovery.

Author information

1
Reagent and Assay Development, AstraZeneca R&D, Mölndal, Sweden. mattias.rohman@astrazeneca.com.
2
Screening Sciences, AstraZeneca R&D, Cambridge, UK.

Abstract

In order to detect a biochemical analyte with a mass spectrometer (MS) it is necessary to ionize the analyte of interest. The analyte can be ionized by a number of different mechanisms, however, one common method is electrospray ionization (ESI). Droplets of analyte are sprayed through a highly charged field, the droplets pick up charge, and this is transferred to the analyte. High levels of salt in the assay buffer will potentially steal charge from the analyte and suppress the MS signal. In order to avoid this suppression of signal, salt is often removed from the sample prior to injection into the MS. Traditional ESI MS relies on liquid chromatography (LC) to remove the salt and reduce matrix effects, however, this is a lengthy process. Here we describe the use of RapidFire™ coupled to a triple-quadrupole MS for high-throughput screening. This system uses solid-phase extraction to de-salt samples prior to injection, reducing processing time such that a sample is injected into the MS ~every 10 s.

KEYWORDS:

Electrospray (ESI); High-throughput screening; Ionization; Mass charge (m/z); Mass spectrometry; RapidFire™; Triple-quadrupole mass spectrometry

PMID:
27316987
DOI:
10.1007/978-1-4939-3673-1_3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center